You have been told many times the data to which you refer is not actual short interest but trade balancing. FINRA members are required to report short interest only semi-monthly.
Merrill Matthews, an alleged scholar at the Institute for Policy Innovation, wrote in a USA Today column ("Keystone pipeline mysteries") on September 4:
"From following the contentious Keystone pipeline debate, you can be forgiven if you think that the fight is over whether to build it. That's not quite right. The Keystone system has already been transporting oil sands from Canada to U.S. refineries in the Midwest for three years — with no major leaks. The Keystone XL project that has received so much attention is the last phase of a larger project. Phase 1 has been operating since 2010, carrying oil from Alberta across three Canadian provinces and six states to refineries in Illinois. Phase 2 expanded the system from Steele City, Neb., to Cushing, Okla., a major U.S. oil refining and storing hub. It went operational two years ago, again with no major problems. Phase 3, under construction, extends the pipeline from Oklahoma to the Gulf Coast refineries in Texas. President Obama even gave a speech in Cushing in March 2012 — during his re-election bid — praising the pipeline extension as good for the economy. Phase 4, the Keystone XL, would build another extension to the pipeline system from Alberta, crossing only three states (Montana, South Dakota then Nebraska)."
Darn it, hadalzone, your last comment (re: "the big sale") is exactly what causes me to hesitate in taking the ten-spot per share profit earned in the past three weeks. May have to put on a stop limit against my better judgment.
Not today, but resolved the problem in the past by selecting and deleting all Yahoo! cookies (Internet Options/Settings/View Files - select and shift+delete).
Could the amended and restated credit agreement be in play? Limitations are placed on use of loan proceeds, and recent dividends have been classified as return of capital (i.e., exceeded net income). Also, one limitation on dividend payments is "the Revolving Commitments [cannot] exceed the Aggregate Revolving Credit Exposure by an amount equal to or greater than ten percent (10%) of the Revolving Commitment. Perhaps the Haynesville and Eagle Ford purchases pierced the limit.
Acknowledgment of prospective viability of the technology by NIH is a significant milestone, but a larger immediate cash infusion from licensing HemoDefend would have been better.
Many bought here heavy at 45? You can't be serious. Fewer than 2M shares traded from March 26 - 27, 2012, the only two days MAKO traded at 45.
October - March typically is when refining stocks run. Hope Barron's didn't pay too much for that insight.
Yes, and about time we got that sub-$7 print. Time to dive in again and collect the dividend immediately, too.
They are trying to persuade somebody - anybody - to buy all those shares being sold through LPC
Completion of the clinical trial leading to the CE Mark was delayed two years beyond the originally anticipated conclusion due to slow patient enrollment and protocol changes. The CE Mark "surprise" was just symptomatic of the poor communications to which CTSO retail shareholders have become accustomed.
The same novice investors should be wary of mindless pumpers as well, not to suggest makenlight is among them. Key to identifying the mindless pumper is recognizing their abbreviated but repeated comments usually begin with some form of the phrase, "I think," frequently in reference to some impending event that will make them rich, rather than presenting facts or fact-based analyses. The pumpers, like the bashers, don't seem to know when to quit.
Price action this morning suggests the investment community really was impressed with VLO"S near-term prospects.
You would have known if you read papa tweek's "Case Report Poster" post preceding yours by three hours.
AH, since VLO plans to sell their 20% by year-end, I will be content to sell out on the heels of the dividend announcement if we can get a $30-$32 print. I do anticipate being able to replace the shares at a significant discount, and $27-$28 sounds about right for a secondary pricing. I suppose that is what the sellers of the 9M shares short are thinking, too.